Stock Code
688016.SH
This website may store cookies on your browser. Cookies are mostly used to make the website work as you expect it to. No cookie will directly identify you, but it can give you a more personalized browsing experience.
Endovastec respects your privacy rights, so you can block some types of cookies. Technically non-essential cookies and tracking mechanisms, that enable us to provide you with customized offers (marketing cookies), are only used if you have given prior consent to such use.
By clicking "Save", only the cookies you selected will be used. You can with draw the consent that you granted here at any time by going to Cookies Settings. For more information, please see our Cookie Policy.
Stock Code
688016.SH
Product Introduction
Aegis™ Bifurcated Aortic Stent Graft System is indicated for abdominal aortic aneurysms involving the common iliac artery. It is the only stent graft in China that adopts a one-piece structure. The stent straddles the bifurcation of the aorta to avoid the risk of distal displacement; the one-piece design is easy to operate and requires no contralateral incision and limb connection. It also eliminates the risk of type III endoleak. It is the first choice for local aneurysm stenosis and abdominal aortic dissection. In addition, it can provide a tailored design for the patient.
● One-piece design, designed for it
● Anatomical sealing, no long-term displacement
Product Feature
Specification Parameter
Brochure
Click here
About us
News
Products
Investor Relations
Telephone:(86) (21) 38139300
Address:Building #1,3399 Kangxin Rd., SIMZ Century Medicine Park, Shanghai201318,P.R. China
Fax:(86) (21) 33750026
©Copyright 1998-2020, Shanghai MicroPort Endovascular MedTech（Group）Co., Ltd.
Internet Drug Information Service Qualification Certificate No.: (Hu) - Non-operating -2024-0188
Website record/ license No.：沪ICP备14048493号-1 
HGWA Bei No.31011502014536
The registered trademarks of “微创", "MicroPort" and"
" are registered trademarks of Shanghai MicroPort Medical (Group) Co., Ltd., they have been authorized to be used by Shanghai MicroPort Endovascular MedTech (Group) Co., Ltd., and no other party shall use such trademarks without prior written permission thereof.
